News | Artificial Intelligence | August 19, 2019

Lunit Receives Korea MFDS Approval for Lunit Insight MMG

Artificial intelligence-based breast cancer detection solution aims to improve effectiveness of mammography screening and reduce unnecessary biopsies

Lunit Receives Korea MFDS Approval for Lunit Insight MMG

August 19, 2019 — Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution for breast cancer, Lunit Insight MMG. The announcement marks the second approval of its AI solution by Korea MFDS since 2018, when Lunit had gained initial regulatory clearance of its AI software.

Lunit Insight MMG, which is now available for domestic sales in Korea, runs on Lunit’s proprietary AI technology, co-developed with Korean medical institutions including Yonsei Severance Hospital, Asan Medical Center and Samsung Medical Center. 

The software analyzes mammography images, with an indication of the location of lesions suspicious for breast cancer and an abnormality score of the detected lesion.

According to Lunit CEO Brandon Suh, breast cancer is one of the most common female cancer, taking up to 24 percent of all female cancer cases. He added that among the patients suspicious of breast cancer after screening mammography, only 29 percent are actually diagnosed with cancer after biopsy.

Suh said that the company is using AI to increase the effectiveness of mammography screening and reduce unnecessary biopsies. According to the company, the algorithm is designed to assist prompt and accurate diagnosis by physicians, by showing only malignant lesions and automatically ignoring benign lesions. It has been trained with more than 200,000 mammography cases, which includes 50,000 breast cancer cases.

Lunit provides an online demo for users to test the performance of its software. 

The company had previously received MFDS clearance in August 2018 for its AI solution for chest X-ray. The software is currently being used at multiple hospitals and medical examination centers throughout the country, including Seoul National University Hospital.

For more information: www.lunit.io

Related Content

Results of Journal of the American College of Surgeons study should reassure breast cancer patients who experienced surgical postponements due to COVID-19 pandemic

Association between Time to Operation and Pathological Stage in DCIS & ER+ Breast Cancer. Courtesy of American College of Surgeons

News | Women's Health | August 07, 2020
August 7, 2020 — A new br...
Versatile, future-proof digital imaging unit scales to meet growing technology needs of customers
News | Digital Radiography (DR) | August 06, 2020
August 6, 2020 — Carestream Health has launched its...
Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
New Medical Imaging and Data Resource Center will aid AI development and medical advancement to battle COVID-19

Getty Images

News | Coronavirus (COVID-19) | August 05, 2020
August 5, 2020 — The nation’s largest medical imaging associations are working together to develop the new Medical Im
Mobile CT scanner reimagines head imaging of critically ill patients by enabling patients and staff to remain in ICU
News | Computed Tomography (CT) | August 05, 2020
August 5, 2020 — The Food and Drug Administration (FDA) has cleared the...
Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their annual mammograms now that healthcare facilities across the nation are re-opening their doors following closures due to the COVID-19 pandemic.

Nine-time GRAMMY Award winner and breast cancer survivor Sheryl Crow has served as the spokesperson for Hologic’s Genius 3D Mammography exam for nearly five years.

News | Breast Imaging | August 03, 2020
August 3, 2020 — Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their ann
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
A World Health Organization (WHO) rapid advice guide on the use of chest imaging in the diagnosis and management of COVID-19 was published in the journal Radiology.

Getty Images

News | Coronavirus (COVID-19) | July 30, 2020
July 30, 2020 — A World Health Organization (WHO) rapid advice gui